NCT00730197View on ClinicalTrials.gov

Fasting Bioequivalence Study of Nisoldipine Extended-Release Tablets 40 mg

PHASE1CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

February 28, 2007

Primary Completion Date

March 31, 2007

Study Completion Date

March 31, 2007

Conditions
Healthy
Interventions
DRUG

Albuterol Sulfate Extended-Release Tablets 8 mg

8mg, single dose fed

DRUG

VoSpire® ER Tablets 8 mg

8mg, single dose fed

Trial Locations (1)

58104

PRACS Institute, Ltd., Fargo

Sponsors
All Listed Sponsors
lead

Mylan Pharmaceuticals Inc

INDUSTRY

NCT00730197 - Fasting Bioequivalence Study of Nisoldipine Extended-Release Tablets 40 mg | Biotech Hunter | Biotech Hunter